Gilead Sciences, Inc. (GILD): A Bull Case Theory

We came across a bullish thesis on Gilead Sciences, Inc. (NASDAQ:GILD) on Substack by Magnus Ofstad. In this article, we will summarize the bulls’ thesis on GILD. Gilead Sciences, Inc. (NASDAQ:GILD)’s share was trading at $91.41 as of Jan 3rd. GILD’s forward P/E was 12.11 according to Yahoo Finance.

Jarun Ontakrai/Shutterstock.com

Gilead Sciences (NASDAQ:GILD) is positioned for significant growth, driven by its breakthrough HIV prevention drug, Lenacapavir, and advancements in its...